With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 30 January 2026 up to and including 5 ...
Krka Group (LJSE:KRK) reported record first-half results for 2025 during its July 24 presentation, with sales exceeding €1 billion for the first time in a half-year period. The Slovenian ...
LJUBLJANA (Reuters) - Slovenian generic drugs producer Krka said on Thursday it expected group net profit to rise only marginally to 161 million euros ($201.1 million) in 2009, from the 160 million ...
Acquisition of treasury shares - komunikat spółki KRKA, TOVARNA ZDRAVIL D.D. (krka) - komunikat ESPI
Grupa Krka zakończyła pierwsze półrocze 2025 r. z 246,7 mln euro zysku netto, co oznacza wzrost o 11 proc. rok do roku. Słoweńska spółka farmaceutyczna poprawiła również wyniki operacyjne i EBITDA.
Krka achieved record Q1 2025 sales of €522.1 million, representing a 7% increase year-over-year. More impressively, net profit soared by 51% to reach €152.5 million, driven by both operational ...
Krka (KRKG) has delivered a 44.51% change over the past year, with a 52-week range between 150.50 and 239.00. What Is the Average Daily Trading Volume of Krka (KRKG)? The average daily trading volume ...
As of 8:02:18 AM GMT+1. Market Open.
LJUBLJANA, Nov 21 (Reuters) - Slovenian pharmaceutical producer Krka made a group net profit of 171.9 million euros ($190.3 million) in the first nine months of 2019 versus 120.8 million in the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results